Table 1 Patient characteristics and lipid parameters before and after LDL apheresis
From: Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
Before treatment | After treatment | Change in % | |
|---|---|---|---|
Age (years) | 60.57 ± 4.79 | ||
Gender (female/male) | 3/3 | ||
Body mass index (kg/m2) | 26.19 ± 2.14 | ||
Waist circumference (cm) | 101 ± 8.19 | ||
Total cholesterol (mmol/L) | 9.25 ± 1.49 | 4.41 ± 0.99*** | −52.58 |
LDL-C (mmol/L) | 6.92 ± 1.34 | 2.69 ± 0.97*** | −61.84 |
HDL-C (mmol/L) | 1.40 ± 0.31 | 1.24 ± 0.16* | −10.46 |
Apo B (g/L) | 2.10 ± 0.42 | 0.82 ± 0.28*** | −61.49 |
Apo A (g/L) | 1.69 ± 0.19 | 1.44 ± 0.10** | −14.09 |
Creatinine (μmol/L) | 94.33 ± 58.18 | 82.33 ± 52.95** | −13.52 |
Serum chemerin (ng/mL) | 82.34 ± 36.30 | 59.09 ± 24.89** | −27.26 |
Large LDL (%) | 27.36 ± 6.64 | 23.72 ± 4.62 | −12.20 |
Small-dense LDL (%) | 4.86 ± 4.27 | 1.14 ± 1.57** | −83.81 |
Mean LDL size (nm) | 26.64 ± 0.568 | 26.98 ± 0.402* | 0.129 |
Large HDL (%) | 21.08 ± 4.79 | 24.36 ± 4.25 | 16.70 |
Intermediate HDL (%) | 45.16 ± 5.25 | 50.02 ± 3.47 | 11.45 |
Small HDL (%) | 33.76 ± 8.66 | 25.62 ± 5.75** | −23.44 |